What Are the Functions of Albumin in the Body?

Albumin is the most abundant protein in human blood plasma, and it does far more than simply float around. It maintains fluid balance, shuttles dozens of substances through the bloodstream, neutralizes free radicals, protects blood vessel walls, and even influences how the immune system responds to infection. Because it touches so many systems at once, a drop in albumin levels can ripple outward into problems that seem unrelated to each other, from swelling in the legs to altered drug responses.

Keeping Fluid Where It Belongs

The function most people hear about first is albumin’s role in oncotic pressure, the pulling force that keeps water inside blood vessels rather than letting it leak into surrounding tissues. Albumin is responsible for the majority of this force in the bloodstream. When albumin levels fall, fluid seeps out of the vascular space and accumulates in places it shouldn’t, producing the puffiness and swelling commonly called edema.

The mechanics of this are more nuanced than the textbook version. Rather than simply exerting pressure across the entire vessel wall, albumin interacts closely with a thin, gel-like coating on the inner surface of blood vessels called the endothelial glycocalyx. This layer is made of proteoglycans, glycoproteins, and other molecules, and albumin physically binds into it, helping stabilize its structure.¹ The oncotic pressure difference that actually matters for fluid balance is built up within a narrow, protein-free zone just beneath this glycocalyx layer, not simply between the blood and the tissue space at large.² Disruption of the glycocalyx breaks down both fluid and protein handling in the vascular bed, which is why albumin’s structural role in that coating matters just as much as its raw osmotic pull.

Research on heart tissue has shown that administering albumin can preserve the glycocalyx’s ultrastructure during injury. In animal models of ischemia-reperfusion injury, albumin administration maintained the glycocalyx and prevented shedding of its components through a specific signaling receptor.³ So albumin isn’t just passively sitting in the blood exerting pressure. It actively protects the barrier that keeps your blood vessels working properly.

The Body’s All-Purpose Cargo Carrier

Albumin is sometimes called the body’s taxi service, and the comparison holds up surprisingly well. It has multiple binding pockets on its surface, each suited to different types of molecular passengers. The sheer variety of substances it carries is part of what makes it so important.

Fatty Acids

Free fatty acids are a crucial energy source, but they don’t dissolve easily in blood. Albumin solves this problem by providing roughly seven binding sites for fatty acids, with moderate to high affinity, boosting their effective concentration in the bloodstream by several orders of magnitude.⁴ Without albumin ferrying them, fatty acids would be present at biologically useless concentrations. Research using spin-labeled fatty acids has confirmed that these binding sites behave differently depending on how many fatty acids are loaded onto a single albumin molecule, with rotational behavior changing significantly once about four fatty acids are bound.⁵ This dynamic loading and unloading is what allows albumin to pick up fatty acids from fat stores and deliver them to muscles, the heart, and other tissues that burn them for fuel.

Bilirubin

Bilirubin is a yellow pigment produced when old red blood cells break down. In its unconjugated form, it’s toxic to nerve tissue, and the fraction that floats free in plasma without being bound to albumin is the dangerous part. Albumin acts as a sponge for unconjugated bilirubin, binding it tightly and keeping it safely neutralized during transit to the liver, where it gets processed for excretion. In a mouse model of severe newborn jaundice, albumin infusion increased the plasma’s bilirubin-binding capacity, pulled bilirubin out of brain tissue back into the blood, and reduced levels of the dangerous free fraction, preventing neurological damage and death.⁶ This is why newborns with dangerously high bilirubin sometimes receive albumin as part of their treatment.

Drugs and Other Small Molecules

Many medications travel through the bloodstream bound to albumin. The bound fraction is pharmacologically inactive; only the unbound, free fraction reaches target tissues and produces an effect. This means albumin levels directly influence how strongly a drug acts. In people with chronic kidney disease, albumin’s binding capacity can be altered, changing the pharmacokinetics of common medications in ways that matter for dosing decisions.⁷ A patient with low albumin may have more free drug circulating than expected, potentially increasing both the effect and the side effects of a standard dose.

Metal Ions

Albumin also binds and transports metal ions, including copper and zinc. It grips copper with remarkably high affinity, on the order of picomolar concentrations, meaning it holds on very tightly even when copper is present in tiny amounts. Researchers have proposed that this copper-binding function makes albumin a guardian against the toxic interaction between copper and amyloid-beta peptide in the brain’s extracellular spaces, a process linked to neurodegeneration.⁸ By sequestering copper, albumin may reduce the formation of damaging reactive oxygen species that copper can catalyze in the wrong context.

Antioxidant Shield

Beyond its transport duties, albumin is the dominant antioxidant in blood plasma. Its antioxidant functions come from two features of its structure: it can trap free radicals directly, and it can bind reactive molecules before they cause damage to other tissues. A key player is a free thiol group on one of albumin’s amino acid residues, which can scavenge reactive oxygen and nitrogen species. Because albumin is so abundant in plasma, this thiol group represents the largest pool of circulating antioxidant capacity in the blood.⁹

This matters clinically because oxidative stress drives damage in conditions ranging from heart disease to sepsis. When albumin levels drop or the protein gets structurally modified, the blood’s antioxidant defenses weaken. The protein essentially takes hits on behalf of other molecules, absorbing oxidative damage so that more fragile structures like cell membranes and DNA are spared.

A Reservoir for Nitric Oxide

Nitric oxide is a signaling molecule that tells blood vessels to relax and widen, which is essential for regulating blood pressure and blood flow. The problem is that nitric oxide is extremely short-lived in the body. Albumin helps solve this by acting as a reservoir, absorbing nitric oxide and its reactive intermediates into its hydrophobic interior. Research has shown that at normal physiological concentrations of nitric oxide, albumin becomes saturated with it and then accelerates the formation of smaller nitric oxide carriers that can deliver the signal downstream.¹⁰ In effect, albumin acts as a buffer that smooths out the supply of nitric oxide so that vascular tone remains stable rather than swinging wildly with each burst of production.

Modulating the Immune Response

Albumin’s involvement with the immune system is subtler and still being worked out, but the evidence points to genuine immunomodulatory effects. It can bind bacterial products, essentially sequestering pieces of bacteria that would otherwise trigger an overblown inflammatory reaction. In critically ill patients with sepsis, albumin’s potential benefits appear to include maintaining vascular integrity and dampening excessive inflammation.¹¹ The protein may also help transport antibiotics to infection sites more effectively.¹²

That said, the clinical evidence for routine albumin use in sepsis remains mixed. While the biological mechanisms are plausible and well-supported by laboratory work, translating those benefits into consistent survival improvements in large clinical trials has been difficult. The immunomodulatory role of albumin is real, but how best to exploit it therapeutically is still an open question.

How Albumin Production Is Regulated

The liver produces virtually all the albumin in the body, churning out roughly 10 to 15 grams per day in a healthy adult. What’s less well known is how precisely this production is tuned by signals from the immune system. During inflammation, a signaling molecule called interleukin-1 directly suppresses albumin gene expression in liver cells. In rats with experimentally induced inflammation, albumin levels in the blood and albumin messenger RNA in the liver both dropped markedly, and the researchers traced the cause specifically to interleukin-1 rather than to stress hormones or other inflammatory byproducts.¹³

Work in isolated liver cells confirmed the mechanism at the gene level: interleukin-1 simultaneously ramped up production of acute-phase proteins like serum amyloid A while dialing down albumin gene expression, and this regulation happened before translation, at the level of messenger RNA abundance.¹⁴ This is why albumin levels often drop during serious illness or surgery. The liver is deliberately shifting its protein-making priorities toward infection-fighting molecules, and albumin gets deprioritized. Low albumin in a hospitalized patient doesn’t always mean malnutrition; it frequently reflects the body’s inflammatory state.

Why Albumin Lasts So Long in the Bloodstream

Albumin has an unusually long half-life for a blood protein, roughly 19 to 21 days in humans. Most proteins of similar size would be broken down much faster. The secret is a recycling mechanism involving a receptor called the neonatal Fc receptor, or FcRn. When cells lining blood vessels take up albumin through normal fluid-phase uptake, FcRn grabs onto it inside acidic compartments within the cell and routes it back to the cell surface for release, rather than sending it to be degraded. Research using engineered albumin variants has directly demonstrated this: albumin molecules engineered to bind FcRn more tightly were recycled more efficiently by endothelial cells and circulated longer in living animals.¹⁵

This recycling pathway is now being harnessed for drug design. By fusing therapeutic molecules to albumin or to albumin-binding domains, pharmaceutical developers can dramatically extend how long a drug stays active in the body. The same receptor that gives natural albumin its long life can be co-opted to give engineered drugs a similar advantage.

Albumin as Medicine in Liver Disease

Because albumin does so many things at once, giving it as a therapy can address multiple problems simultaneously. The strongest clinical evidence for albumin infusions is in patients with advanced cirrhosis and ascites, the buildup of fluid in the abdomen. Albumin is used in several specific scenarios in these patients: preventing circulatory collapse after large-volume paracentesis (fluid drainage), treating kidney dysfunction triggered by spontaneous bacterial peritonitis, and managing hepatorenal syndrome.¹⁶

Long-term albumin infusions have shown real promise in this population. In a randomized trial of 100 patients with first-onset ascites, those receiving regular albumin infusions alongside diuretics had significantly better survival, with a mean increase of 16 months, and far fewer episodes of ascites recurrence compared to patients on diuretics alone.¹⁷

But the picture isn’t uniformly positive. A larger, more recent randomized trial in hospitalized cirrhosis patients found that targeting higher albumin levels through aggressive infusions did not reduce a composite of infection, kidney dysfunction, or death compared to standard care, and the albumin group actually experienced more severe adverse events.¹⁸ The difference between these results likely comes down to context: long-term outpatient albumin supplementation in stable patients with ascites appears beneficial, while aggressive short-term albumin loading in acutely hospitalized patients may not be, and can even cause harm. The clinical takeaway is that albumin therapy in cirrhosis needs to be targeted to specific indications rather than used as a blanket strategy to raise levels.

Ischemia-Modified Albumin as a Diagnostic Clue

When tissues experience reduced blood flow or oxidative stress, albumin itself gets chemically altered. The resulting form, called ischemia-modified albumin, has a reduced ability to bind transition metals like copper, nickel, and cobalt.¹⁹ This change can be measured in a blood test, and elevated levels of ischemia-modified albumin have been studied as an early marker for heart attacks and stroke.²⁰

More recently, researchers have found that ischemia-modified albumin rises in conditions that involve oxidative stress without necessarily involving blood flow obstruction, including certain skin diseases.²¹ This has expanded the potential applications of the test beyond cardiology, though it also means a positive result is less specific than initially hoped. Ischemia-modified albumin is better understood as a marker of oxidative damage to the protein itself rather than a pinpoint indicator of any single disease.

When Albumin Gets Damaged by Sugar and Metals

In conditions like diabetes, chronically elevated blood sugar leads to glycation of albumin, a process in which glucose molecules attach to the protein’s surface and alter its shape. Metal ions such as copper and zinc can accelerate this damage. Research has found that metal-induced oxidative modifications to glycated albumin impair its antioxidant properties and promote the formation of abnormal protein aggregates resembling those seen in neurodegenerative diseases. These aggregates showed toxic activity to brain immune cells in laboratory experiments.²²

This finding connects several dots. If albumin is both the body’s primary antioxidant in blood and the primary carrier of copper and zinc, then damage to albumin in diabetes could create a vicious cycle: the damaged protein loses its protective capacity against the very oxidative stress that damaged it, while also releasing metal ions that can do further harm. Understanding how glycation compromises albumin function is an active area of research, particularly in explaining why people with diabetes are at higher risk for both cardiovascular and neurological complications.

The Evolutionary Staying Power of Albumin

Albumin is not unique to humans. It belongs to a protein family found across vertebrates, from fish to mammals, and comparative genomic analysis has shown that albumin genes are remarkably conserved throughout vertebrate evolution.²³ The fact that so many distantly related species have retained albumin in recognizable form speaks to the difficulty of replacing a single molecule that manages fluid balance, transport, antioxidant defense, and vascular protection all at once. Losing albumin, or even allowing it to drift too far from its current structure, would break multiple systems simultaneously. Evolution, in effect, had a hard time improving on the design once it existed, so it mostly left it alone.